The drug discovery services market today is influenced by technological advancements and growing demand for cancer treatment. What is fueling the growth of this market is people’s increasing concern about chronic diseases, growing patient pool, increasing government assistance, and enhancing the regulatory framework, among other reasons. Steady advancements in the drug discovery technologies are paving the way for new and unique products.
The drug discovery service providers aim at providing unique services that span the drug discovery continuum. Methods like molecular manipulation, molecular designing, and random screening have been specifically designed to reduce the cost of drug discovery. Bottom line: to reduce costs and timelines, and meet drug discovery milestones, it is of utmost importance to seek drug discovery domain experts. By paying heed to the customers’ unique requirements, the dedicated specialists and the domain experts handle screening, customer assay, development, and profiling that helps the industry to extend the research team by offering assistance before, during, and after the experiments. Moreover, the services delivered help in predicting answers during the research. Since the dynamic pharmaceutical industry requires an advanced level of specialized assistance and expertise from life science tool suppliers, adopting the best and relevant drug discovery services is the need of the hour.
In this edition of Pharma Tech Outlook, we bring the list of top 10 drug discovery consulting/services companies in APAC. The edition features Axcelead, a Japan-based pharma and biotech company that helps drug institutes streamline the implementation of drug discovery procedures. The company offers a one-stop-shop service tailored to the needs of each process. As the best partner for doctors, specialists, and researches of drugs, Axcelead tackles various challenges in the drug discovery space. Also, its High-Throughput Screening (HTS) service helps in finding high-quality compounds with a major probability of success hit identification regardless of target difficulty.
Another company that finds its place in the list is Gemseki, a company that has contributed immensely to the pharmaceutical industry. The company serves as a connecting agent for licensing-in/licensing-out of drug candidates, drug discovery technologies, and therapeutic targets. Gemseki provides a detailed summary of the candidate drugs or technologies when inquired. Based on the information, customers can choose to involve in the process of due diligence.
Similarly, PharmAbcine, a research-oriented biotech company, focuses on the development of therapeutic antibodies. The company has created many pipelines under clinical development. For commercializing antibody therapeutics PharmAbcine’s services come across one of the best choices. Also, the cost and scope of every service are determined through prior consultation.
With several innovative services and success stories up their sleeves, these companies are constantly proving their ability in the drug discovery expanse. We hope this issue of Pharma Tech Outlook helps you build the partnership you and your firm needs to drive success.
We present to you Pharma Tech Outlook’s “Top 10 Drug Discovery Consulting/Services Companies in APAC 2019.”
